Cleared Traditional

K061188 - SILVERHAWK PERIPHERAL PLAQUE EXCISION SYSTEM

K061188 is an FDA 510(k) clearance for SILVERHAWK PERIPHERAL PLAQUE EXCISION S..., manufactured by Foxhollow Technologies, Inc.. The device is a Class 2 Cardiovascular device with product code MCW cleared through the Traditional 510(k) pathway after a 178-day FDA review.

K061188 · Foxhollow Technologies, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2006
Decision
178d
Days
Class 2
Risk

K061188 is an FDA 510(k) clearance for the SILVERHAWK PERIPHERAL PLAQUE EXCISION SYSTEM. Classified as Catheter, Peripheral, Atherectomy (product code MCW), Class II - Special Controls.

Submitted by Foxhollow Technologies, Inc. (Redwood City, US). The FDA issued a Cleared decision on October 23, 2006 after a review of 178 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Foxhollow Technologies, Inc. devices

FDA 510(k) Submission Details - K061188

510(k) Number K061188 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 28, 2006
Decision Date October 23, 2006
Days to Decision 178 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d slower than avg
Panel avg: 125d · This submission: 178d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MCW Device Classification - Class 2, Special Controls

Product Code MCW Catheter, Peripheral, Atherectomy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4875
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MCW Catheter, Peripheral, Atherectomy

All 108
Devices cleared under the same product code (MCW) and FDA review panel - the closest regulatory comparables to K061188.
DIAMONDBACK 360 DEGREE ORBITAL ATHERECTOMY SYSTEM FOR TREATMENT OF A-V SHUNT STENOSIS
K071427 · Cardiovascular Systems, Inc. · Aug 2007
THROMCAT THROMBECTOMY CATHETER SYSTEM
K072195 · Kensey Nash Corp. · Aug 2007
DIAMONDBACK 360 DEGREE ORBITAL ATHERECTOMY SYSTEM
K071350 · Cardiovascular Systems, Inc. · Aug 2007
THROMCAT THROMBECTOMY CATHETER SYSTEM
K060016 · Kensey Nash Corp. · Apr 2006
BAXTER PERCUTANEOUS MECHANICAL THROMBECTOMY (PMT) DEVICE, MODELS PMT0606FD AND PMT1206FD
K993816 · Baxter Edwards · May 2000
POSSIS ANGIOJET X-STREAM RHEOLYTIC THROMBECTOMY CATHETER, MODEL 103587-002
K993564 · Possis Medical, Inc. · Apr 2000